Dynamic Neuromuscular Stabilization vs Pelvic Floor Muscle Training in Women With Stress Urinary Incontinence
Launched by IZMIR KATIP CELEBI UNIVERSITY · Jul 10, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different exercise programs to help women who have stress urinary incontinence (SUI), which is when you accidentally leak urine during activities like coughing, sneezing, or exercising. The researchers want to see how well Dynamic Neuromuscular Stabilization (DNS), a type of training that focuses on improving muscle coordination and stability, works compared to Pelvic Floor Muscle Training (PFMT), which involves exercises to strengthen the muscles that support the bladder. They will look at changes in muscle function, urinary symptoms, quality of life, and other related areas before and after the 12-week programs.
Women between 18 and 65 years old who have been diagnosed with stress urinary incontinence and can voluntarily contract their pelvic floor muscles may be eligible to join. Participants will be randomly placed into one of three groups: DNS exercises, PFMT exercises, or a control group that only receives advice about lifestyle and bladder health. Those in the exercise groups will do home exercises five days a week, at least three times a day, and also attend supervised sessions at the clinic twice weekly. The study aims to find out which approach might be more helpful in improving symptoms and daily life for women with this condition.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female participants aged between 18 and 65 years
- • Diagnosed with stress urinary incontinence or stress-dominant mixed urinary incontinence by a specialist physician
- • Having the ability to voluntarily contract the pelvic floor muscles
- • Literate in Turkish
- • Willing and voluntarily consenting to participate in the study
- Exclusion Criteria:
- • Pregnancy
- • Presence of urgency-predominant urinary incontinence symptoms or fecal incontinence
- • Inability to understand or cooperate with assessment procedures
- • Presence of any neurological or rheumatological disease
- • Severe cardiac or pulmonary disease
- • Uncontrolled diabetes mellitus or hypertension
- • Chronic liver and/or kidney failure
- • Advanced pelvic organ prolapse (greater than grade 2)
- • History of abdominal or pelvic surgery (including cesarean section) within the past year
- • History of spinal surgery
- • Current urinary tract infection
- • History of pelvic radiation therapy
- • Presence of spinal deformity
- • History of acute low back pain within the past 4-6 weeks
- • Receiving pelvic floor muscle training within the past three months
About Izmir Katip Celebi University
Izmir Katip Celebi University is a prominent academic institution in Turkey, dedicated to advancing medical research and education. The university is committed to fostering innovation and excellence in clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of experienced researchers and healthcare professionals. With a focus on improving patient outcomes and contributing to the global body of medical knowledge, Izmir Katip Celebi University actively engages in collaborative research initiatives, aiming to address critical health challenges through rigorous scientific inquiry and ethical practices in clinical trial management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İzmir, , Turkey
Patients applied
Trial Officials
Ayse Kardelen ACAR, MSc
Principal Investigator
Izmir Katıp Celebi University, Institute of Health Sciences
Sevtap GUNAY UCURUM, Associate Professor
Study Director
Izmir Katıp Celebi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Ahmet Ozgur YENIEL, Professor
Study Chair
Ege University, Faculty of Medicine, Department of Obstetrics & Gynecology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported